New Drug Data Alert – Atogepant: Heads UP–Episode 69

[fusion_builder_container hundred_percent="yes" overflow="visible" type="legacy" admin_label="post"][fusion_builder_row][fusion_builder_column type="1_1" layout="1_1" background_position="left top" background_color="" border_color="" border_style="solid" spacing="yes" background_image="" background_repeat="no-repeat" padding_top="" padding_right="" padding_bottom="" padding_left="" margin_top="0px" margin_bottom="0px" class="" id="" animation_type="" animation_speed="0.3" animation_direction="left" hide_on_mobile="no" center_content="no" min_height="none" align_self="flex-start" border_sizes_undefined="" first="true" last="true" hover_type="none" link="" border_position="all" type="1_1"][fusion_text columns="" column_min_width="" column_spacing="" rule_style="default" rule_size="" rule_color="" content_alignment_medium="" content_alignment_small="" content_alignment="" hide_on_mobile="small-visibility,medium-visibility,large-visibility" sticky_display="normal,sticky" class="" id="" font_size="" fusion_font_family_text_font="" fusion_font_variant_text_font="" line_height="" letter_spacing="" text_color="" animation_type="" animation_direction="left" animation_speed="0.3" animation_offset=""][fusion_dropcap color="" boxed="yes" boxed_radius="50%" class="" id=""]N[/fusion_dropcap]ew data was revealed this month on the upcoming gepant indicated for migraine prevention called Atogepant. Dr. Lindsay Weitzel questions Dr. Tim Smith about its safety and effectiveness in Episode 69 of Heads UP. How will we take it and how often? Also, when will it be available?[/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]